Form 4: Vericel Corp Director Lisa Wright Reports Stock Vesting

Director Lisa Wright reports the vesting of restricted stock units into 434 shares of Vericel Corp common stock on June 3, 2024.

Summary

• Lisa Wright, a director of Vericel Corporation, reported a transaction involving the vesting of restricted stock units (RSUs).
• On June 3, 2024, 434 shares of common stock were acquired due to the vesting of RSUs.
• These RSUs were granted on June 1, 2021, and vest in equal annual installments over three years.
• Following the transaction, Wright directly owns 9,451 shares of Vericel Corp common stock.

Sentiment

Score: 5

Explanation: This is a neutral report on a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.

Positives

• The vesting of RSUs indicates that the director is meeting the conditions of their equity compensation plan.

Future Outlook

The document does not contain any specific forward-looking statements about the company's future performance.

Industry Context

This is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency into the equity holdings of company insiders.

Comparison to Industry Standards

• Equity compensation through RSUs is a standard practice among publicly traded companies to align the interests of executives with those of shareholders.
• The vesting schedule of three years is also a common vesting period for RSUs.

Key Dates